Unknown Facts About Cannabis Flower Made Known > 자유게시판

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Gross profit before FV adjustments on cannabis net revenue is calculated by subtracting (i) cost of sales, before the effects of changes in FV of biological assets and inventory, and (ii) cost of sales from non-cannabis ancillary support functions, from total cannabis net revenue. Adjusted gross profit before FV adjustments on cannabis net revenue represents cash gross profit and gross margin on cannabis net revenue and is calculated by subtracting from total cannabis net revenue (i) cost of sales, before the effects of changes in FV of biological assets and inventory; (ii) cost of sales from non-cannabis ancillary support functions; and removing (iii) depreciation in cost of sales; (iv) cannabis inventory impairment; and (v) out-of-period adjustments. Adjusted EBITDA is calculated as net income (loss) excluding interest income (expense), accretion, income taxes, depreciation, amortization, changes in fair value of inventory sold, changes in fair value of biological assets, share-based compensation, acquisition costs, foreign exchange, share of income (losses) from investment in associates, government grant income, fair value gains and losses on financial instruments, gains and losses on deemed disposal, losses on disposal of assets, restructuring charges, onerous contract provisions, out-of-period adjustments, and non-cash impairments of deposits, property, plant and equipment, equity investments, intangibles, goodwill, and according to locksmith (500PX.Com) other assets.

Average net selling price per gram and gram equivalent is further broken down as follows: - Average net selling price per gram of dried cannabis represents the average net selling price per gram for locksmith dried cannabis sales only, excluding wholesale bulk cannabis sold in the period. Q4 2021 total cannabis net revenue1 was $54.8 million, essentially flat sequentially, and here’s a great place to get started 19% decrease in over fiscal Q4 of the prior year. Adjusted EBITDA1 loss improved to $19.3 million in Q4 2021 ($13.9 million loss excluding restructuring charges) compared to the prior year Adjusted EBITDA loss1 of $33.3 million ($31.5 million loss excluding restructuring charges) primarily driven by the substantial decrease in SG&A and R&D expenses and an increase in gross margins. SG&A, including Research and Development ("R&D"), was $44.8 million, excluding $5.2 million in severance and restructuring costs ($49.9 million reported), down $19.1 million or 30% from the prior year as a result of our business transformation plan.

This was primarily driven by an increase in cost of sales due to under-utilized capacity at Aurora Sky as a result of the scaling back production (expected to partially reverse in future quarters), offset by an increase in the consumer cannabis sales mix attributed to our core and premium brands, contributing to an increase in our average net selling price per gram of dried cannabis. Adjusted gross margin before fair value adjustments on cannabis net revenue1 was 44% in Q3 2021, versus 43% in Q3 2020. The increase in adjusted gross margin is due to a significant shift in revenue mix towards our medical markets which command much higher average net selling prices, partially offset by the purposeful reduction in production levels at Sky resulting in charges related to under-utilization of capacity. If you have any concerns regarding exactly where and how to use locksmith home page, you can contact us at our web site. Adjusted gross margin before fair value adjustments on cannabis net revenue1 was 54% in Q4 2021 versus 49% in the prior year period and 44% in Q3 2021. The increase in Adjusted gross margin compared to Q4 2020 is due primarily to a shift in sales mix towards the medical market which commands higher average net selling prices and margins. Reflecting the shift in mix toward our medical businesses, the Q3 2021 average net selling price per gram of dried cannabis1 increased to $5.00 per gram from $4.64 in Q3 2020 and more info $4.45 in Q2 2021. This excludes the impact of the Q3 2021 bulk wholesale of excess lower-potency cannabis flower at clear-out pricing.

Aurora materially improved its balance sheet during fiscal year 2021 through a number of purposeful actions including repaying the credit facility in full in June 2021, which resulted in interest and principal repayment reductions of approximately $25 million annually. Aurora will host a conference call today, September 27, 2021, to discuss these results. In Q4 2021, Aurora managed cash flow tightly using $7.8 million in cash to fund operations, including working capital investments and restructuring and severance payments of $5.1 million. The Company’s focus on realizing operational efficiencies and ability to manage cash has greatly improved operating cash flow; reducing the need for incremental capital. Approximately 60% of the savings are expected to be driven out of our network through asset consolidation, and operational and supply chain efficiencies. We are now delighted to announce a long-term supply agreement with Cantek in Israel that we expect to provide us with a steady stream of high-margin revenue that could also evolve into a larger partnership over time.